...
首页> 外文期刊>ACS catalysis >Cobalt-Catalyzed Alkylation of Drug-Like Molecules and Pharmaceuticals Using Heterocyclic Phosphonium Salts
【24h】

Cobalt-Catalyzed Alkylation of Drug-Like Molecules and Pharmaceuticals Using Heterocyclic Phosphonium Salts

机译:使用杂环鏻盐催化药物样分子和药物的烷基化

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Alkylated pyridines are common in pharmaceuticals, and metal catalysis is frequently used to prepare this motif via Csp(2)-Csp(3) coupling processes. We present a cobalt-catalyzed coupling reaction between pyridine phosphonium salts and alkylzinc reagents that can be applied to complex drug-like fragments and for late-stage functionalization of pharmaceuticals. The reaction generally proceeds at room temperature, and 4-position pyridine C-H bonds are the precursors in this strategy. Given the challenges in selectively installing (pseudo)halides in complex pyridines, this two-step process enables sets of molecules to be alkylated that would be challenging using traditional cross-coupling methods.
机译:烷基化吡啶在药物中是常见的,并且通常使用金属催化来通过CSP(2)-CSP(3)偶联方法制备该基序。 我们在吡啶鏻盐和烷基三锌试剂之间呈现钴催化的偶联反应,其可用于复杂的药物状片段和药物的后期官能化。 反应通常在室温下进行,4-位吡啶C-H键是该策略中的前体。 鉴于在复合吡啶中选择性地安装(假)卤化物中的挑战,这两步方法使得一组分子可以烷基化,这将采用传统的交叉偶联方法具有挑战性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号